Abortive HIV Infection Mediates CD4 T Cell Depletion and Inflammation in Human Lymphoid Tissue
Overview
Authors
Affiliations
The mechanism by which CD4 T cells are depleted in HIV-infected hosts remains poorly understood. In ex vivo cultures of human tonsil tissue, CD4 T cells undergo a pronounced cytopathic response following HIV infection. Strikingly, >95% of these dying cells are not productively infected but instead correspond to bystander cells. We now show that the death of these "bystander" cells involves abortive HIV infection. Inhibitors blocking HIV entry or early steps of reverse transcription prevent CD4 T cell death while inhibition of later events in the viral life cycle does not. We demonstrate that the nonpermissive state exhibited by the majority of resting CD4 tonsil T cells leads to accumulation of incomplete reverse transcripts. These cytoplasmic nucleic acids activate a host defense program that elicits a coordinated proapoptotic and proinflammatory response involving caspase-3 and caspase-1 activation. While this response likely evolved to protect the host, it centrally contributes to the immunopathogenic effects of HIV.
Immune Alterations and Viral Reservoir Atlas in SIV-Infected Chinese Rhesus Macaques.
Clain J, Picard M, Rabezanahary H, Andre S, Boutrais S, Goma Matsetse E Infect Dis Rep. 2025; 17(1).
PMID: 39997464 PMC: 11855486. DOI: 10.3390/idr17010012.
Zhang T, Shi Y, Komarova N, Wordaz D, Kostelny M, Gonzales A Nat Commun. 2025; 16(1):1641.
PMID: 39952916 PMC: 11829055. DOI: 10.1038/s41467-025-56771-4.
Cell-free assays reveal that the HIV-1 capsid protects reverse transcripts from cGAS immune sensing.
Scott T, Arnold L, Powers J, McCann D, Rowe A, Christensen D PLoS Pathog. 2025; 21(1):e1012206.
PMID: 39874383 PMC: 11793794. DOI: 10.1371/journal.ppat.1012206.
Xia S, Gu X, Wang G, Zhong Y, Ma F, Liu Q J Inflamm Res. 2024; 17:11419-11436.
PMID: 39722732 PMC: 11669335. DOI: 10.2147/JIR.S497775.
Georgakis S, Orfanakis M, Brenna C, Burgermeister S, Del Rio Estrada P, Gonzalez-Navarro M Vaccines (Basel). 2024; 12(8).
PMID: 39204036 PMC: 11359267. DOI: 10.3390/vaccines12080912.